Shares of Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) have been assigned a consensus rating of "Hold" from the fourteen analysts that are presently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $18.0417.
A number of brokerages have commented on DOC. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a report on Monday, January 5th. Morgan Stanley reduced their target price on Healthpeak Properties from $21.00 to $18.00 and set an "overweight" rating for the company in a report on Tuesday, April 28th. Weiss Ratings reissued a "hold (c-)" rating on shares of Healthpeak Properties in a research note on Friday, April 24th. Argus cut shares of Healthpeak Properties from a "buy" rating to a "hold" rating in a research note on Thursday, February 5th. Finally, Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Saturday.
View Our Latest Report on Healthpeak Properties
Healthpeak Properties Stock Performance
NYSE DOC opened at $16.44 on Friday. The stock has a market capitalization of $11.43 billion, a price-to-earnings ratio of 164.42, a PEG ratio of 2.27 and a beta of 1.00. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $19.68. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. The stock has a 50-day moving average of $16.94 and a 200 day moving average of $17.16.
Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.02. The company had revenue of $719.40 million during the quarter, compared to analysts' expectations of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.Healthpeak Properties's quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Sell-side analysts anticipate that Healthpeak Properties will post 1.74 EPS for the current fiscal year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 7.4%. The ex-dividend date of this dividend is Monday, June 15th. Healthpeak Properties's payout ratio is 1,220.00%.
Institutional Investors Weigh In On Healthpeak Properties
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. CoreCap Advisors LLC grew its position in shares of Healthpeak Properties by 22.4% in the third quarter. CoreCap Advisors LLC now owns 3,352 shares of the real estate investment trust's stock valued at $64,000 after purchasing an additional 613 shares in the last quarter. Fiduciary Trust Co grew its position in shares of Healthpeak Properties by 4.9% in the third quarter. Fiduciary Trust Co now owns 13,807 shares of the real estate investment trust's stock valued at $264,000 after purchasing an additional 644 shares in the last quarter. Patton Fund Management Inc. grew its position in shares of Healthpeak Properties by 5.2% in the fourth quarter. Patton Fund Management Inc. now owns 13,002 shares of the real estate investment trust's stock valued at $209,000 after purchasing an additional 648 shares in the last quarter. Arjuna Capital grew its position in shares of Healthpeak Properties by 4.8% in the third quarter. Arjuna Capital now owns 14,768 shares of the real estate investment trust's stock valued at $283,000 after purchasing an additional 679 shares in the last quarter. Finally, Quadrant Capital Group LLC grew its position in shares of Healthpeak Properties by 1.9% in the third quarter. Quadrant Capital Group LLC now owns 37,650 shares of the real estate investment trust's stock valued at $721,000 after purchasing an additional 718 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Company Profile
(
Get Free Report)
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.